
Amsel Medical Corp
Innovative occlusion solutions for venous disease with high efficacy and reduced recurrence.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
* | $1.5m | Grant | |
Total Funding | 000k |
Related Content
Amsel Medical Corporation, founded in 2011 in Cambridge, MA by renowned Vascular Surgeon Arnold Miller, MD, specializes in developing advanced medical devices for the treatment of venous diseases. The company's flagship product, the Amsel Occluder Device, is designed for use in open general surgery procedures on tubular structures or vessels, offering a permanent solution where traditional treatments like lasers, RF, glue, and sclerotherapy fall short. Amsel Medical serves healthcare providers and institutions, primarily targeting vascular surgeons and hospitals. Operating in the medical device market, the company generates revenue through the sale of its FDA-cleared and CE Mark-cleared products. With a strong leadership team and advisory board, Amsel Medical aims to set a new standard in venous disease treatment, reducing ulcer recurrence, costs, and patient morbidity.
Keywords: venous disease, occlusion, medical devices, vascular surgery, FDA clearance, CE Mark, ulcer recurrence, healthcare providers, Amsel Occluder, vascular surgeons.